Mycobacterium shimoidei-cavitary pulmonary disease with favorable outcome. 2018

Vide Popovic, and Dragan Arar, and Dragica Roso Popovic, and Igor Barisic, and Marija Tonkic, and Irena Peric, and Anita Novak, and Zana Rubic, and Vera Katalinic-Jankovic, and Mateja Jankovic Makek, and Ivana Goic-Barisic
Clinic for Respiratory Disease, University Hospital of Split, Split, Croatia.

We report a case of cavitary pulmonary disease caused by Mycobacterium shimoidei in 67-year-old female with history of asthma. Even though susceptibility testing was not available, choice of treatment regimen (streptomycin, rifampicin, ethambutol, and clarithromycin), based on a few cases with favorable outcome reported in the literature, resulted with an excellent clinical, microbiological, and radiological response. This is the first report of pulmonary disease caused by M. shimoidei, but also the first ever isolation of M. shimoidei in Croatia.

UI MeSH Term Description Entries
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D009165 Mycobacterium Infections, Nontuberculous Infections with nontuberculous mycobacteria (atypical mycobacteria): M. kansasii, M. marinum, M. scrofulaceum, M. flavescens, M. gordonae, M. obuense, M. gilvum, M. duvali, M. szulgai, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. xenopi (littorale), M. ulcerans, M. buruli, M. terrae, M. fortuitum (minetti, giae), M. chelonae, M. leprae. Mycobacterium Infections, Atypical,Atypical Mycobacterial Infection, Disseminated,Atypical Mycobacterial Infection, Familial Disseminated,Atypical Mycobacteriosis, Familial,Atypical Mycobacteriosis, Familial Disseminated,Atypical Mycobacterium Infections,Infections, Atypical Mycobacterium,Mycobacterium abscessus Infection,Atypical Mycobacterium Infection,Familial Atypical Mycobacterioses,Familial Atypical Mycobacteriosis,Infection, Mycobacterium abscessus,Infections, Mycobacterium abscessus,Mycobacterioses, Familial Atypical,Mycobacteriosis, Familial Atypical,Mycobacterium Infection, Atypical,Mycobacterium Infection, Nontuberculous,Mycobacterium abscessus Infections,Nontuberculous Mycobacterium Infection,Nontuberculous Mycobacterium Infections
D009170 Nontuberculous Mycobacteria So-called atypical species of the genus MYCOBACTERIUM that do not cause tuberculosis. They are also called tuberculoid bacilli, i.e.: M. abscessus, M. buruli, M. chelonae, M. duvalii, M. flavescens, M. fortuitum, M. gilvum, M. gordonae, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. kansasii, M. marinum, M. obuense, M. scrofulaceum, M. szulgai, M. terrae, M. ulcerans, M. xenopi. Atypical Mycobacteria,Mycobacteria, Atypical,Mycobacterium duvalii,Mycobacterium flavescens,Mycobacterium gilvum,Mycobacterium gordonae,Mycobacterium obuense,Mycobacterium szulgai,Mycobacterium terrae,Mycolicibacter terrae,Mycolicibacterium duvalii,Mycolicibacterium flavescens,Mycolicibacterium gilvum,Mycolicibacterium obuense,Tuberculoid Bacillus,Atypical Mycobacterium,Mycobacterium, Atypical,Non-Tuberculous Mycobacteria,Nontuberculous Mycobacterium
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin
D013307 Streptomycin An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis. Estreptomicina CEPA,Estreptomicina Clariana,Estreptomicina Normon,Strepto-Fatol,Strepto-Hefa,Streptomycin GrĂ¼nenthal,Streptomycin Sulfate,Streptomycin Sulfate (2:3) Salt,Streptomycin Sulphate,Streptomycine Panpharma,Strepto Fatol,Strepto Hefa
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Vide Popovic, and Dragan Arar, and Dragica Roso Popovic, and Igor Barisic, and Marija Tonkic, and Irena Peric, and Anita Novak, and Zana Rubic, and Vera Katalinic-Jankovic, and Mateja Jankovic Makek, and Ivana Goic-Barisic
August 1991, Journal of clinical microbiology,
Vide Popovic, and Dragan Arar, and Dragica Roso Popovic, and Igor Barisic, and Marija Tonkic, and Irena Peric, and Anita Novak, and Zana Rubic, and Vera Katalinic-Jankovic, and Mateja Jankovic Makek, and Ivana Goic-Barisic
October 2013, Journal of clinical microbiology,
Vide Popovic, and Dragan Arar, and Dragica Roso Popovic, and Igor Barisic, and Marija Tonkic, and Irena Peric, and Anita Novak, and Zana Rubic, and Vera Katalinic-Jankovic, and Mateja Jankovic Makek, and Ivana Goic-Barisic
January 2013, The American journal of case reports,
Vide Popovic, and Dragan Arar, and Dragica Roso Popovic, and Igor Barisic, and Marija Tonkic, and Irena Peric, and Anita Novak, and Zana Rubic, and Vera Katalinic-Jankovic, and Mateja Jankovic Makek, and Ivana Goic-Barisic
January 2000, Scandinavian journal of infectious diseases,
Vide Popovic, and Dragan Arar, and Dragica Roso Popovic, and Igor Barisic, and Marija Tonkic, and Irena Peric, and Anita Novak, and Zana Rubic, and Vera Katalinic-Jankovic, and Mateja Jankovic Makek, and Ivana Goic-Barisic
August 2006, Kekkaku : [Tuberculosis],
Vide Popovic, and Dragan Arar, and Dragica Roso Popovic, and Igor Barisic, and Marija Tonkic, and Irena Peric, and Anita Novak, and Zana Rubic, and Vera Katalinic-Jankovic, and Mateja Jankovic Makek, and Ivana Goic-Barisic
April 1990, Canada diseases weekly report = Rapport hebdomadaire des maladies au Canada,
Vide Popovic, and Dragan Arar, and Dragica Roso Popovic, and Igor Barisic, and Marija Tonkic, and Irena Peric, and Anita Novak, and Zana Rubic, and Vera Katalinic-Jankovic, and Mateja Jankovic Makek, and Ivana Goic-Barisic
March 2022, Infectious medicine,
Vide Popovic, and Dragan Arar, and Dragica Roso Popovic, and Igor Barisic, and Marija Tonkic, and Irena Peric, and Anita Novak, and Zana Rubic, and Vera Katalinic-Jankovic, and Mateja Jankovic Makek, and Ivana Goic-Barisic
November 2017, Emerging infectious diseases,
Vide Popovic, and Dragan Arar, and Dragica Roso Popovic, and Igor Barisic, and Marija Tonkic, and Irena Peric, and Anita Novak, and Zana Rubic, and Vera Katalinic-Jankovic, and Mateja Jankovic Makek, and Ivana Goic-Barisic
December 2022, Antimicrobial agents and chemotherapy,
Vide Popovic, and Dragan Arar, and Dragica Roso Popovic, and Igor Barisic, and Marija Tonkic, and Irena Peric, and Anita Novak, and Zana Rubic, and Vera Katalinic-Jankovic, and Mateja Jankovic Makek, and Ivana Goic-Barisic
March 2023, The Journal of infectious diseases,
Copied contents to your clipboard!